共 457 条
- [71] Liu MB(2019)Genomic instability, inflammatory signaling and response to cancer immunotherapy Ann Oncol 30 undefined-undefined
- [72] Jiang X(2019)Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic Nat Genet 51 undefined-undefined
- [73] Song T(2022)Tumor mutational load predicts survival after immunotherapy across multiple cancer types Nat Rev Drug Discov 21 undefined-undefined
- [74] Feng SX(2019)Identification of neoantigens for individualized therapeutic cancer vaccines J Hematol Oncol 12 undefined-undefined
- [75] Wu JY(2021)Tumor neoantigens: from basic research to clinical applications Cancer Immunol Immunother 70 undefined-undefined
- [76] Deng PF(undefined)Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma undefined undefined undefined-undefined
- [77] Wang XY(undefined)undefined undefined undefined undefined-undefined
- [78] Villanueva L(undefined)undefined undefined undefined undefined-undefined
- [79] Alvarez-Errico D(undefined)undefined undefined undefined undefined-undefined
- [80] Esteller M(undefined)undefined undefined undefined undefined-undefined